297 related articles for article (PubMed ID: 34228969)
1. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
Rashid MH; Babu D; Siraki AG
Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
[TBL] [Abstract][Full Text] [Related]
2. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
4. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
[TBL] [Abstract][Full Text] [Related]
5. Quinone oxidoreductases and vitamin K metabolism.
Gong X; Gutala R; Jaiswal AK
Vitam Horm; 2008; 78():85-101. PubMed ID: 18374191
[TBL] [Abstract][Full Text] [Related]
6. NRH:quinone oxidoreductase2 (NQO2).
Long DJ; Jaiswal AK
Chem Biol Interact; 2000 Dec; 129(1-2):99-112. PubMed ID: 11154737
[TBL] [Abstract][Full Text] [Related]
7. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.
Dinkova-Kostova AT; Talalay P
Arch Biochem Biophys; 2010 Sep; 501(1):116-23. PubMed ID: 20361926
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.
Strassburg A; Strassburg CP; Manns MP; Tukey RH
Mol Pharmacol; 2002 Feb; 61(2):320-5. PubMed ID: 11809856
[TBL] [Abstract][Full Text] [Related]
10. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
Gaikwad NW; Yang L; Rogan EG; Cavalieri EL
Free Radic Biol Med; 2009 Jan; 46(2):253-62. PubMed ID: 18996184
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
12. NQO1 and NQO2 regulation of humoral immunity and autoimmunity.
Iskander K; Li J; Han S; Zheng B; Jaiswal AK
J Biol Chem; 2006 Oct; 281(41):30917-24. PubMed ID: 16905546
[TBL] [Abstract][Full Text] [Related]
13. Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Jamieson D; Tung AT; Knox RJ; Boddy AV
Br J Cancer; 2006 Nov; 95(9):1229-33. PubMed ID: 17031400
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme.
Janda E; Nepveu F; Calamini B; Ferry G; Boutin JA
Mol Pharmacol; 2020 Nov; 98(5):620-633. PubMed ID: 32913139
[No Abstract] [Full Text] [Related]
15. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
Gong X; Kole L; Iskander K; Jaiswal AK
Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
[TBL] [Abstract][Full Text] [Related]
16. In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
Nolan KA; Caraher MC; Humphries MP; Bettley HA; Bryce RA; Stratford IJ
Bioorg Med Chem Lett; 2010 Dec; 20(24):7331-6. PubMed ID: 21074425
[TBL] [Abstract][Full Text] [Related]
17. NRH:quinone oxidoreductase 2 (NQO2) protein competes with the 20 S proteasome to stabilize transcription factor CCAAT enhancer-binding protein α (C/EBPα), leading to protection against γ radiation-induced myeloproliferative disease.
Xu J; Patrick BA; Jaiswal AK
J Biol Chem; 2013 Nov; 288(48):34799-808. PubMed ID: 24142791
[TBL] [Abstract][Full Text] [Related]
18. The ontogeny and population variability of human hepatic dihydronicotinamide riboside:quinone oxidoreductase (NQO2).
Riches Z; Liu Y; Berman JM; Walia G; Collier AC
J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28346733
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
[TBL] [Abstract][Full Text] [Related]
20. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
